http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005070464-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c259c76558d186c6f1b586e2a39cb816
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_739eeaaf79d4d1dd364005166abeb9d1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6a8f8816698b69643454088aac826122
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2013
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2059
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4365
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4365
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
filingDate 2005-01-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7bec66005b791ac9cde454ee6ea5c156
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb74cb18f5291631241883f5a84b25ba
publicationDate 2005-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2005070464-A3
titleOfInvention A tablet formulation of clopidogrel bisulphate
abstract This invention comprises a new formulation which solves the stability problems of a thieno pyridine derivative, anthitrombotic clopidogrel bisulphate compositions. The object of the present invention is to use a new lubricant other than magnesium stearate which cause degradation in thieno[3,2-c] pyridine derivatives. Another object of the invention is to form a new formulation and to increase stability.
priorityDate 2004-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0112194-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004026879-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0066130-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0789875-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1310245-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005048992-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004074215-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60606
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396698
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67500
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11177
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226466635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12210218
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412361
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45051774
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396699
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9861403
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393830
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226426033
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393829
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID115366
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420157
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11647133

Total number of triples: 40.